Drug Profile
Tick anticoagulant peptide
Latest Information Update: 08 Aug 2002
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Peptides
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Reperfusion injury; Thrombosis